Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy?
作者信息
Lawn Stephen D, Wood Robin
出版信息
Int J Tuberc Lung Dis. 2012 Aug;16(8):995-6. doi: 10.5588/ijtld.12.0364.
Abstract
摘要
相似文献
1
Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy?
Int J Tuberc Lung Dis. 2012 Aug;16(8):995-6. doi: 10.5588/ijtld.12.0364.
2
A new tool for monitoring isoniazid preventive therapy.
Int J Tuberc Lung Dis. 2013 Mar;17(3):424. doi: 10.5588/ijtld.12.1008.
3
Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa.
Int J Tuberc Lung Dis. 2012 Aug;16(8):1020-2. doi: 10.5588/ijtld.11.0744. Epub 2012 Jun 5.
4
Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study.
Lancet Glob Health. 2018 Apr;6(4):e426-e435. doi: 10.1016/S2214-109X(18)30022-6. Epub 2018 Feb 19.
5
Implementation of isoniazid preventive therapy for HIV-infected adults: overstatement of district reports.
Int J Tuberc Lung Dis. 2014 Aug;18(8):1005. doi: 10.5588/ijtld.13.0855.
6
Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy.
Int J Tuberc Lung Dis. 2009 Aug;13(8):925-6.
7
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
AIDS. 2009 Mar 13;23(5):631-6. doi: 10.1097/QAD.0b013e328327964f.
8
Survey of isoniazid preventive therapy in South Africa, 2011.
Int J Tuberc Lung Dis. 2012 Jul;16(7):903-7. doi: 10.5588/ijtld.11.0722. Epub 2012 May 7.
9
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
Lancet. 2016 Mar 19;387(10024):1198-209. doi: 10.1016/S0140-6736(16)00546-8.
10
The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
Thorax. 2011 Jun;66(6):496-501. doi: 10.1136/thx.2010.156752. Epub 2011 Apr 2.
引用本文的文献
1
Landscape of TB Infection and Prevention among People Living with HIV.
Pathogens. 2022 Dec 16;11(12):1552. doi: 10.3390/pathogens11121552.
2
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
N Engl J Med. 2019 Mar 14;380(11):1001-1011. doi: 10.1056/NEJMoa1806808.
3
Scale-up of collaborative TB/HIV activities in Guyana.
Rev Panam Salud Publica. 2017 Apr 20;41:e6. doi: 10.26633/RPSP.2017.6.
4
Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped.
AIDS. 2014 Jun 19;28(10):1463-72. doi: 10.1097/QAD.0000000000000278.
本文引用的文献
1
Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa.
Int J Tuberc Lung Dis. 2012 Aug;16(8):1020-2. doi: 10.5588/ijtld.11.0744. Epub 2012 Jun 5.
2
What is thwarting tuberculosis prevention in high-burden settings?
N Engl J Med. 2011 Jul 7;365(1):79-81. doi: 10.1056/NEJMe1105555.
3
New regimens to prevent tuberculosis in adults with HIV infection.
N Engl J Med. 2011 Jul 7;365(1):11-20. doi: 10.1056/NEJMoa1005136.
4
6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.
Lancet. 2011 May 7;377(9777):1588-98. doi: 10.1016/S0140-6736(11)60204-3. Epub 2011 Apr 12.
5
Treatment of latent tuberculosis infection in HIV infected persons.
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD000171. doi: 10.1002/14651858.CD000171.pub3.
Zotero 插件